MedKoo Cat#: 574132 | Name: Phenelfamycin E
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Phenelfamycin E is an antibiotic active against β-hemolytic Streptoccus, S. pneumoniae, C. difficile, C. perfringens, and P. magnus Gram-positive bacteria. Phenelfamycin E increases survival in a mouse model of lethal S. pyogenes infection in a dose-dependent manner. Dietary administration of phenelfamycin E increases body weight in chickens.

Chemical Structure

Phenelfamycin E
Phenelfamycin E
CAS#114451-31-9

Theoretical Analysis

MedKoo Cat#: 574132

Name: Phenelfamycin E

CAS#: 114451-31-9

Chemical Formula: C65H95NO21

Exact Mass: 1225.6397

Molecular Weight: 1226.46

Elemental Analysis: C, 63.66; H, 7.81; N, 1.14; O, 27.39

Price and Availability

Size Price Availability Quantity
1mg USD 600.00
5mg USD 1,560.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Ganefromycin α, Phenelfamycin E
IUPAC/Chemical Name
(2E,4E,6E)-7-((2S,3S,5R)-5-((2S,3S,4E,6E)-8-((S)-2-((2R,3R,4R,6S)-2,4-dihydroxy-5,5-dimethyl-6-((1E,3Z)-penta-1,3-dien-1-yl)-3-(2-phenylacetoxy)tetrahydro-2H-pyran-2-yl)-3-(((2R,4S,5R,6S)-5-(((2R,4R,5S,6S)-5-(((2S,4S,5R,6S)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)propanamido)-3-methoxy-4-methylocta-4,6-dien-2-yl)-3-hydroxytetrahydrofuran-2-yl)hepta-2,4,6-trienoic acid
InChi Key
UDVVGDCMWCVRCO-WOPDTIQPSA-N
InChi Code
InChI=1S/C65H95NO21/c1-13-14-18-29-51-64(7,8)61(72)62(84-53(70)32-43-26-19-17-20-27-43)65(74,87-51)44(63(73)66-31-24-23-25-38(2)58(78-12)39(3)47-33-45(67)46(83-47)28-21-15-16-22-30-52(68)69)37-79-54-35-49(76-10)59(41(5)81-54)86-56-36-50(77-11)60(42(6)82-56)85-55-34-48(75-9)57(71)40(4)80-55/h13-30,39-42,44-51,54-62,67,71-72,74H,31-37H2,1-12H3,(H,66,73)(H,68,69)/b14-13-,16-15+,24-23+,28-21+,29-18+,30-22+,38-25+/t39-,40-,41-,42-,44+,45-,46-,47+,48-,49-,50+,51-,54+,55-,56+,57+,58+,59+,60-,61-,62+,65+/m0/s1
SMILES Code
C[C@@H]([C@@]1([H])C[C@H](O)[C@H](/C=C/C=C/C=C/C(O)=O)O1)[C@H](OC)/C(C)=C/C=C/CNC([C@@]([C@]2(O)[C@H](OC(CC3=CC=CC=C3)=O)[C@H](O)C(C)(C)[C@H](/C=C/C=C\C)O2)([H])CO[C@H]4C[C@H](OC)[C@H](O[C@@]5([H])O[C@@H](C)[C@H](O[C@@]6([H])C[C@H](OC)[C@H](O)[C@H](C)O6)[C@H](OC)C5)[C@H](C)O4)=O
Appearance
Solid powder
Purity
>95% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Phenelfamycin E is an antibiotic active against β-hemolytic Streptoccus, S. pneumoniae, C. difficile, C. perfringens, and P. magnus Gram-positive bacteria.
In vitro activity:
TBD
In vivo activity:
TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 1,226.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1. Hochlowski, J.E., Buytendorp, M.H., Whittern, D.N., et al. Phenelfamycins, a novel complex of elfamycin-type antibiotics. II. Isolation and structure determination. J. Antibiot. (Tokyo) 41(10), 1300-1305 (1988). 2. Maiese, W.M., Lechevalier, M.P., Lechevalier, H.A., et al. LL-E19020 α and β, animal growth promoting antibiotics: taxonomy, fermentation and biological activity. J. Antibiot. (Tokyo) 42(10), 1489-1493 (1989).